115
Recorrente: O depositante. @Despacho: Recurso conhecido e negado o provimento. Mantida a decisão recorrida. [115]
05/21/2024
RPI 2785
Back to search
Application data
Number
122023022069Type
Utility Model
Filing
05/27/2016
Publication
-
PCT
IB2016000857 Progress at the INPI
- Filing05/27/16
- Publication
- Examination
- Refused05/21/24
- Grant
- In force
The application was refused on 05/21/2024 and the appeal did not change the decision. The invention was never patented and the technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 05/21/2024. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
LUMOSA THERAPEUTICS CO., LTD.
TW
SHANGHAI LUMOSA THERAPEUTICS CO., LTD.
CN
Inventors
No inventors listed.
Technical data
IPC Classification
No IPC classification.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Pedido de recurso
#12.3
Recurso: 870240007045 - 26/1/2024
02/06/2024
RPI 2770
11.12
Dividido do PCT 11 2017 025395-0
11/28/2023
RPI 2760
Requerimento de pedido de patente
#2.10
Número de Protocolo '870230093844' em 23/10/2023 16:43 (WB)
10/31/2023
RPI 2756
Related
From the same holder
D0009 PARA TRATAMENTO DE ACIDENTE VASCULAR CEREBRAL ISQUÊMICO AGUDOCOMPOSIÇÃO FARMACÊUTICA COMPREENDENDO CONJUGADO DE PEPTÍDEO TROMBOLÍTICO-TETRAIDROISOQUINOLINACOMPOSIÇÕES E MÉTODOS PARA TRATAR PRURIDOPROTEÍNAS DE FUSÃO DE ANTICORPO CITOSINA-DESAMINASE DE DOMÍNIO ÚNICOFORMULAÇÕES FARMACÊUTICAS PARA LIBERAÇÃO PROLONGADA DE SEBACOIL ÉSTER DE DINALBUFINA
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.